Back to Journals » Neuropsychiatric Disease and Treatment » Volume 1 » Issue 3
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4182)
- Volume 20, 2024 (76)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 1, 2005
Frontotemporal dementia: remembering images from the past
Paul Mackin, R Hamish McAllister-Williams
Neuropsychiatric Disease and Treatment 2005, 1:281-283
Published Date: 15 October 2005
Response of pyromania to biological treatment in a homeless person
Randolph W Parks, Russell DJ Green, Sobhi Girgis, Michael D Hunter, Peter WR Woodruff, Sean A Spence
Neuropsychiatric Disease and Treatment 2005, 1:277-280
Published Date: 15 October 2005
Differential effects of acute diazepam on emotional and neutral memory tasks in acutely hospitalized depressed patients
Vera B Delgado, Ivan Izquierdo, Márcia LF Chaves
Neuropsychiatric Disease and Treatment 2005, 1:269-275
Published Date: 15 October 2005
Mood fluctuations in Parkinson’s disease: a pilot study comparing the effects of intravenous and oral levodopa administration
Irene Hegeman Richard, Samuel Frank, Kori A LaDonna, Hongkun Wang, Michael P McDermott, Roger Kurlan
Neuropsychiatric Disease and Treatment 2005, 1:261-268
Published Date: 15 October 2005
Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect ||Reprinted in Neuropsychiatric Disease and Treatment 2005, 1(4) 365–372||
Charlotte Wiker, Love Linnér, Marie-Louise Wadenberg, Torgny H Svensson
Neuropsychiatric Disease and Treatment 2005, 1:253-260
Published Date: 15 October 2005
Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial
Frederick W Reimherr, Dawson W Hedges, Robert E Strong, Barrie K Marchant, Erika D Williams
Neuropsychiatric Disease and Treatment 2005, 1:245-251
Published Date: 15 October 2005
Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder
Bruno Aouizerate, Dominique Guehl, Emmanuel Cuny, Alain Rougier, Pierre Burbaud, Jean Tignol, Bernard Bioulac
Neuropsychiatric Disease and Treatment 2005, 1:231-243
Published Date: 15 October 2005
Genetic influences in emotional dysfunction and alcoholism-related brain damage
Marlene Oscar-Berman, Abdalla Bowirrat
Neuropsychiatric Disease and Treatment 2005, 1:211-229
Published Date: 15 October 2005
Progress in understanding conversion disorder
Matthew Allin, Anna Streeruwitz, Vivienne Curtis
Neuropsychiatric Disease and Treatment 2005, 1:205-209
Published Date: 15 October 2005
Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications
Peter F Buckley
Neuropsychiatric Disease and Treatment 2005, 1:193-204
Published Date: 15 October 2005
Editorial: International Neuropsychiatric Association || FREE PAPER ||
Perminder Sachdev
Neuropsychiatric Disease and Treatment 2005, 1:191-192
Published Date: 15 October 2005